SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Avalon Pharmaceuticals (AVRX)
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
9 1 0 AVRX
Emcee:  Paul Chiu Type:  Unmoderated
Introduction Market Data Compact
Avalon Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. Their pipeline of drug candidates includes their lead candidate, AVN944. AVN944 is an oral delivery, small molecule drug candidate that was discovered by Vertex Pharmaceuticals Incorporated and that they licensed from Vertex in February 2005.

IPO date is 9/26/2005

Pricing $10 to $12

Shares 2,750,000

Lead Manager: WR Hambrecht + Co.

Is this company worth it?
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9Avalon Pharmaceuticals and Merck & Co., Inc. Establish a Drug Discovery, Devsjemmeri-3/6/2007
8There was an Edgar filing dated 1/19/2007, probably on the private placement of Paul Chiu-1/26/2007
7Interested in this one based on tiny market cap and pipeline but have concerns tmcbio-1/26/2007
6I have. There are no cashflows to value.... Comparables are worthless as well..Paul Chiu-10/8/2005
5I have some ideas, but whether any of them have merit is a different question. IRutgers-10/7/2005
4Any idea how to value this?Paul Chiu-10/7/2005
3Key Stats: Avalon Pharmaceuticals, Inc. 20358 Seneca Meadows Parkway GermantownRutgers-10/7/2005
2Avalon dual lists on electronic stock exchange bizjournals.com Avalon PharmaceRutgers-10/7/2005
1From 9/29/2005 AVRX Biotech Avalon Pharmaceuticals, a genomics company developinRutgers-10/7/2005
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News